SAR

240 drugs in development·79 companies·1 clinical trial

Drug Pipeline by Phase

Approved(23)
Phase 3(52)
DrugCompany
actinomycin dGH Research PLC (GHRS)
azd3152ASTRAZENECA PLC (AZN)
azenosertibZentalis Pharmaceuticals, Inc. (ZNTL)
azenosertib (ZN-c3)Zentalis Pharmaceuticals, Inc. (ZNTL)
bivalent BNT162b2BioNTech SE (BNTX)
bivalent bnt162b2 10 microgram doseBioNTech SE (BNTX)
bivalent bnt162b2 3 microgram doseBioNTech SE (BNTX)
bivalent bnt162b2 6 microgram doseBioNTech SE (BNTX)
BNT162b2BioNTech SE (BNTX)
BNT162b2 BivalentBioNTech SE (BNTX)
BNT162b2 Bivalent 30 mcgBioNTech SE (BNTX)
BNT162b2 Monovalent 30 mcgBioNTech SE (BNTX)
BNT162b2 OMIBioNTech SE (BNTX)
BNT162b4 10 mcgBioNTech SE (BNTX)
BNT162b4 15 mcgBioNTech SE (BNTX)
BNT162b4 30 mcgBioNTech SE (BNTX)
BNT162b4 5 mcgBioNTech SE (BNTX)
Cabozantinib S-malateValneva SE (VALN)
cmb305IMMUNE DESIGN CORP. (IMDZ)
Combination BNT162b2 and BNT162b2 OMIBioNTech SE (BNTX)
covid-19-influenza vaccine candidateNOVAVAX INC (NVAX)
Cytomegalovirus vaccineModerna, Inc. (MRNA)
DactinomycinFilana Therapeutics Inc. (FLNA)
DactinomycinMerus N.V. (MRUS)
efzofitimodaTYR PHARMA INC (ATYR)
eribulinINTENSITY THERAPEUTICS, INC. (INTS)
h5n1 avian pandemic influenza vaccine candidateNOVAVAX INC (NVAX)
ibuzatrelvirPFIZER INC (PFE)
int230-6INTENSITY THERAPEUTICS, INC. (INTS)
Investigational mRNA-1273.815Moderna, Inc. (MRNA)
licensed seasonal influenza vaccineNOVAVAX INC (NVAX)
Licensed Spikevax VaccineModerna, Inc. (MRNA)
LurbinectedinCrinetics Pharmaceuticals, Inc. (CRNX)
Norovirus vaccineModerna, Inc. (MRNA)
pazopanibINTENSITY THERAPEUTICS, INC. (INTS)
RP1 (vusolimogene oderparepvec)Replimune Group, Inc. (REPL)
sars-cov-2 rs/matrix m1-adjuvantNOVAVAX INC (NVAX)
Seasonal flu vaccineModerna, Inc. (MRNA)
Single-agent chemotherapyPTC THERAPEUTICS, INC. (PTCT)
spikevax jn.1Moderna, Inc. (MRNA)
SPIKEVAX XModerna, Inc. (MRNA)
stand-alone influenza vaccine candidateNOVAVAX INC (NVAX)
TBI-1301Filana Therapeutics Inc. (FLNA)
tilGH Research PLC (GHRS)
Variant-adapted BNT162b2 10 microgram doseBioNTech SE (BNTX)
Variant-adapted BNT162b2 3 microgram doseBioNTech SE (BNTX)
Variant-adapted BNT162b2 6 microgram doseBioNTech SE (BNTX)
vincristinGH Research PLC (GHRS)
VincristineBlack Diamond Therapeutics, Inc. (BDTX)
vincristine liposomalGH Research PLC (GHRS)
Vinorelbine TartrateFilana Therapeutics Inc. (FLNA)
zyesamiGH Research PLC (GHRS)
Phase 2(45)
DrugCompany
^1^1c-methionineGH Research PLC (GHRS)
AG-120AGIOS PHARMACEUTICALS, INC. (AGIO)
BNT162b5 BivalentBioNTech SE (BNTX)
BNT162b6 BivalentBioNTech SE (BNTX)
BNT162b7 BivalentBioNTech SE (BNTX)
BNT162b7 MonovalentBioNTech SE (BNTX)
Cabozantinib S-malateAssertio Holdings, Inc. (ASRT)
Combination of MK3475 with Metronomic CPDesign Therapeutics, Inc. (DSGN)
Combination of MK3475 with Metronomic CP and G100Design Therapeutics, Inc. (DSGN)
comirnatyVaxart, Inc. (VXRT)
COVID-19 VaccineModerna, Inc. (MRNA)
cyt-0851Cyteir Therapeutics, Inc. (CYT)
DacarbazinePTC THERAPEUTICS, INC. (PTCT)
dexrazoxaneGH Research PLC (GHRS)
EDP-235ENANTA PHARMACEUTICALS INC (ENTA)
Elraglusib InjectionACTUATE THERAPEUTICS, INC. (ACTU)
envafolimabTracon Pharmaceuticals, Inc. (TCON)
ifosfamideBlack Diamond Therapeutics, Inc. (BDTX)
imx-110Immix Biopharma, Inc. (IMMX)
Influenza VaccineModerna, Inc. (MRNA)
isomyosamineQ/C TECHNOLOGIES, INC. (QCLS)
lete-celAdaptimmune Therapeutics PLC (ADAP)
ln-145IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
LurbinectedinJazz Pharmaceuticals plc (JAZZ)
mecbotamab vedotinBioAtla, Inc. (BCAB)
mRNA-1273.214Moderna, Inc. (MRNA)
mRNA-1283Moderna, Inc. (MRNA)
mRNA-1283.211Moderna, Inc. (MRNA)
mRNA-1283.529Moderna, Inc. (MRNA)
myeloid growth factorGH Research PLC (GHRS)
ost-her2OS Therapies Inc (OSTX)
ozekibartInhibrx Biosciences, Inc. (INBX)
PegfilgrastimENANTA PHARMACEUTICALS INC (ENTA)
Pioglitazone Oral ProductMerus N.V. (MRUS)
RegorafenibFilana Therapeutics Inc. (FLNA)
sotigalimabApexigen, Inc. (APGN)
TemozolomideELI LILLY & Co (LLY)
temsirolimusBlack Diamond Therapeutics, Inc. (BDTX)
TrabectedinMerus N.V. (MRUS)
ub-612Vaxxinity, Inc. (VAXX)
UnesbulinPTC THERAPEUTICS, INC. (PTCT)
vincristineGH Research PLC (GHRS)
vinorelbineGH Research PLC (GHRS)
vxa-cov2-3.1Vaxart, Inc. (VXRT)
vxa-cov2-3.3Vaxart, Inc. (VXRT)
Phase 1(49)
DrugCompany
177lu-pnt6555POINT Biopharma Global Inc. (PNT)
ADCT-601ADC Therapeutics SA (ADCT)
adxs-her2OLD AYALA, INC (AYLA)
ADXS-HER2 (ADXS31-164)Ayala Pharmaceuticals, Inc. (ADXS)
B7-H3-CAR T CellsFilana Therapeutics Inc. (FLNA)
B7-H3-CAR T CellsMerus N.V. (MRUS)
CLD-201 (SuperNova™ / SNV1)Calidi Biotherapeutics Inc. (CLDI)
covid-higEmergent BioSolutions Inc. (EBS)
COVID-HIGUNITED THERAPEUTICS Corp (UTHR)
FH FOLR1 ST CAR T-cellsFilana Therapeutics Inc. (FLNA)
FilgrastimBlack Diamond Therapeutics, Inc. (BDTX)
FilgrastimENANTA PHARMACEUTICALS INC (ENTA)
FilgrastimPTC THERAPEUTICS, INC. (PTCT)
fluadModerna, Inc. (MRNA)
FLUAD®Moderna, Inc. (MRNA)
GanitumabBlack Diamond Therapeutics, Inc. (BDTX)
gb-0669Generate Biomedicines Inc. (GENB)
GCAR1Filana Therapeutics Inc. (FLNA)
HDM201Novartis AG (NVS)
INBRX-109PTC THERAPEUTICS, INC. (PTCT)
INBRX-109IGM Biosciences, Inc. (IGMS)
INBRX-109Merus N.V. (MRUS)
incb059872Incyte Corp. (INCY)
lb-100LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
leucovorinInhibrx Biosciences, Inc. (INBX)
LeucovorinPTC THERAPEUTICS, INC. (PTCT)
LN-145IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
mRNA plus Lysate-loaded Dendritic Cell VaccineENANTA PHARMACEUTICALS INC (ENTA)
mRNA-1010Moderna, Inc. (MRNA)
mRNA-1273Moderna, Inc. (MRNA)
mRNA-1345Moderna, Inc. (MRNA)
mRNA-1647Moderna, Inc. (MRNA)
PazopanibPTC THERAPEUTICS, INC. (PTCT)
PazopanibNovartis AG (NVS)
PEEL-224ENANTA PHARMACEUTICALS INC (ENTA)
PEEL-224PTC THERAPEUTICS, INC. (PTCT)
PEEL-224Black Diamond Therapeutics, Inc. (BDTX)
PEEL-224Structure Therapeutics Inc. (GPCR)
PegfilgrastimBlack Diamond Therapeutics, Inc. (BDTX)
PegfilgrastimPTC THERAPEUTICS, INC. (PTCT)
PEGYLATED-INTERFERON ALPHA-2AENANTA PHARMACEUTICALS INC (ENTA)
pemetrexedPTC THERAPEUTICS, INC. (PTCT)
PeposertibMerus N.V. (MRUS)
PeposertibAccustem Sciences Inc. (ACUT)
stealthx vaccineCAPRICOR THERAPEUTICS, INC. (CAPR)
StealthX™ exosome protein-based vaccine (multivalent design)CAPRICOR THERAPEUTICS, INC. (CAPR)
TemozolomideStructure Therapeutics Inc. (GPCR)
trifluridine + tipiracilInhibrx Biosciences, Inc. (INBX)
VincristineStructure Therapeutics Inc. (GPCR)
Unknown(19)

Compare drugs

Frequently asked questions

How many drugs are in development for SAR?

BioSniper tracks 240 drugs in development for SAR across 79 companies.

How many clinical trials target SAR?

There are 1 clinical trial targeting SAR tracked by BioSniper.

Deep-dive into SAR

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis